Escherichia coli transformant for producing itaconate and uses thereof

US2020325503A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020325503-A1
Application numberUS-201916516464-A
CountryUS
Kind codeA1
Filing dateJul 19, 2019
Priority dateApr 11, 2019
Publication dateOct 15, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides an Escherichia coli transformant and a method for producing itaconate using the Escherichia coli transformant.

First claim

Opening claim text (preview).

What is claimed is: 1 . An Escherichia coli transformant, comprising at least one plasmid, wherein the at least one plasmid includes a D-xylose dehydrogenase (XDH) gene, a D-xylonolactonase (XL) gene, a 2-keto-3-deoxy-D-xylonate dehydratase (KdxD) gene, and a 2-ketoglutarate semialdehyde dehydrogenase (KGSADH) gene; wherein an isocitrate dehydrogenase (icd) gene of the Escherichia coli transformant is deleted. 2 . The Escherichia coli transformant according to claim 1 , wherein the at least one plasmid further includes a D-xylonate dehydratase (XD) gene. 3 . The Escherichia coli transformant according to claim 2 , wherein the XDH gene, the XL gene, the KdxD gene, the KGSADH gene, and the XD gene are obtained from Burkholderia xenovorans strains. 4 . The Escherichia coli transformant according to claim 2 , wherein the XDH gene, the XL gene, the XD gene, the KdxD gene, and the KGSADH gene are sequentially constructed from their 5′ ends to 3′ ends in the at least one plasmid. 5 . The Escherichia coli transformant according to claim 1 , which is a transformant of Escherichia coli BW25113 or a transformant of Escherichia coli XL-1 Blue. 6 . The Escherichia coli transformant according to claim 1 , which converts xylose into α-ketoglutaric acid through a nonphosphorylative metabolic pathway. 7 . The Escherichia coli transformant according to claim 1 , wherein a xylose isomerase gene (xylA), a 2-dehydro-3-deoxy-D-pentonate aldolase gene (yjhH), and a 2-keto-3-deoxygluconate aldolase gene (yagE) of the Escherichia coli transformant are deleted. 8 . The Escherichia coli transformant according to claim 1 , further comprising a citrate synthase (gltA), an aconitase B (acn B), and a pyruvate carboxylase (pyc). 9 . The Escherichia coli transformant according to claim 1 , which produces itaconate. 10 . The Escherichia coli transformant according to claim 9 , wherein the Escherichia coli transformant produces itaconate without adding a yeast extract or glutamate. 11 . A method for producing itaconate using the Escherichia coli transformant according to claim 1 , comprising the following steps: (a) transforming the at least one plasmid into cells of Escherichia coli to obtain the Escherichia coli transformant; (b) providing a substrate as a culture environment, wherein the substrate comprises a carbon source, a nitrogen source, minerals, and vitamins; and (c) cultivating the Escherichia coli transformant at a temperature ranging from 30° C. to 37° C. and a dissolved oxygen ranging from 20% to 30%, and inducing the Escherichia coli transformant to produce itaconate. 12 . The method according to claim 11 , wherein the carbon source in step (b) comprises a glycerol, and the nitrogen source is an ammonium salt. 13 . The method according to claim 12 , wherein the carbon source in step (b) further comprises a xylose, and an initial concentration of the xylose is ranging from 2 g/L to 10 g/L. 14 . The method according to claim 11 , wherein the Escherichia coli transformant produces 1.2 g/L to 2.2 g/L itaconate every 24 hours. 15 . The method according to claim 11 , wherein the Escherichia coli transformant produces 19 g/L to 21 g/L itaconate every 90 hours. 16 . The method according to claim 11 , wherein the Escherichia coli transformant produces itaconate without adding a yeast extract or glutamate.

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020325503A1 cover?
The present disclosure provides an Escherichia coli transformant and a method for producing itaconate using the Escherichia coli transformant.
Who is the assignee on this patent?
Univ Nat Tsing Hua, Chang Chun Plastics Co Ltd, Chang Chun Petrochemical Co Ltd, and 1 more
What technology area does this patent fall under?
Primary CPC classification C12P7/44. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Oct 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).